Holen Sie sich die Stockscreener-App
1.72
1.80%
0.01
Schlusskurs vom Vortag:
$1.71
Offen:
$1.72
24-Stunden-Volumen:
3.28M
Relative Volume:
1.72
Marktkapitalisierung:
$155.36M
Einnahmen:
$52.93M
Nettoeinkommen (Verlust:
$-63.95M
KGV:
-2.2894
EPS:
-0.7513
Netto-Cashflow:
$-61.66M
1W Leistung:
+41.52%
1M Leistung:
+45.06%
6M Leistung:
-28.37%
1J Leistung:
-31.20%
1-Tages-Spanne:
$1.67
$1.94
1-Wochen-Bereich:
$1.15
$2.13
52-Wochen-Spanne:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
1.72 | 154.45M | 52.93M | -63.95M | -61.66M | -0.7513 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.99 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
701.04 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.13 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.61 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Cantor Fitzgerald Maintains Overweight on Codexis (CDXS) March 2026 - Meyka
Codexis (CDXS) Stock Jumps 2.4% Following Strong Q4 Earnings Report - MEXC
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative - simplywall.st
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal - Investing.com South Africa
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Stock Rises 2.4% After Q4 Earnings Beat - MEXC
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal By Investing.com - Investing.com India
Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results - Benzinga
Codexis Shines as Q4 Profit Sparks Investor Enthusiasm - StocksToTrade
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com
Codexis Surpasses Q4 Expectations, Stock Price Volatility Anticipated - timothysykes.com
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Benzinga
Codexis (CDXS) Surges on Strong Q4 2025 Results and Optimistic O - GuruFocus
Codexis rises after Q4 beat, strong outlook - MSN
Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript - Insider Monkey
Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ) - Seeking Alpha
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Codexis, Inc. 2025 Annual Report: Advancements in ECO Synthesis Platform and Pharma Biocatalysis for Therapeutics Manufacturing - Minichart
Codexis: Q4 Earnings Snapshot - theheraldreview.com
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Benzinga
Codexis (CDXS) Expects Current Funds to Last Through 2027 - GuruFocus
Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Codexis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Codexis (CDXS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Codexis (CDXS) Surpasses Q4 Expectations for Earnings and Revenue - Bitget
Earnings call transcript: Codexis Surpasses Q4 2025 Expectations with Strong Revenue Growth - Investing.com
CDXS: Strong 2025 revenue and ECO Synthesis progress set the stage for continued growth in 2026 - TradingView
Codexis Q4 Earnings Call Highlights - Yahoo Finance
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Codexis (CDXS) Exceeds Revenue Expectations, Highlights Technolo - GuruFocus
Codexis Q4 2025 Results: $9.6M Profit, 2026 Revenue Forecast $72M-$76MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Codexis 2025 10-K: Revenue $70.4M, EPS $(0.50) - TradingView
Codexis (NASDAQ:CDXS) Releases Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
CODEXIS ($CDXS) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Codexis Q4 Swings to Profit, Revenue Rises - marketscreener.com
Codexis swings to Q4 profit as Merck deal lifts revenue and funds RNAi push - Stock Titan
Preview: Codexis's Earnings - Benzinga
Codexis signs deal to produce siRNA for pharma partner - Investing.com Nigeria
Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf - MarketBeat
Why did CDXS stock jump 7% today? - MSN
Update Recap: Whats next for Codexis Inc stockJuly 2025 Snapshot & Accurate Buy Signal Notifications - baoquankhu1.vn
Why Did CDXS Stock Jump 7% Today? - Stocktwits
Codexis, Inc. Hits New 52-Week Low at $0.96 Amid Financial Struggles - Markets Mojo
Clean the SkyClean Pharmaceutical Manufacturings - Trend Hunter
Codexis signs deal to produce siRNA for pharma partner By Investing.com - Investing.com Canada
Codexis to Produce 50 Grams of siRNA Using ECO Synthesis Manufacturing Platform - geneonline.com
Codexis Agrees to Manufacture 50 Grams of siRNA Using its Proprietary Manufacturing Platform - Contract Pharma
Codexis (CDXS) Partners for siRNA Manufacturing in Cardiovascula - GuruFocus
Biotech Codexis tapped to scale RNA ingredient for heart drug research - Stock Titan
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - Yahoo Finance
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):